Schedule 13G ownership disclosure
INMED PHARMACEUTICALS INC
Common Shares, no par value · CUSIP: 457637601
Event date: 2025-03-31
- Filing-level shares
- 0
- Percent of class
- 0%
- AdvisorShares Trust
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-001453
- Form type
- SCHEDULE 13G/A
- Filer
- AdvisorShares Trust
- CIK
- CIK 1408970
- Filed
- Apr 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership